La Trobe
AAM_1165580_Carli,A_2021.pdf (442.79 kB)

Cancer stem cell marker DCLK1 reprograms small extracellular vesicles toward migratory phenotype in gastric cancer cells

Download (442.79 kB)
Version 2 2023-10-19, 00:53
Version 1 2021-08-04, 01:25
journal contribution
posted on 2021-08-04, 01:23 authored by Annalisa Leandra Elena CarliAnnalisa Leandra Elena Carli, Shoukat Afshar-Sterle, A Rai, H Fang, Ryan O'KeefeRyan O'Keefe, Janson Tse, FM Ferguson, NS Gray, Matthias ErnstMatthias Ernst, David GreeningDavid Greening, Michael BuchertMichael Buchert
Doublecortin-like kinase 1 (DCLK1) is a putative cancer stem cell marker, a promising diagnostic and prognostic maker for malignant tumors and a proposed driver gene for gastric cancer (GC). DCLK1 overexpression in a majority of solid cancers correlates with lymph node metastases, advanced disease and overall poor-prognosis. In cancer cells, DCLK1 expression has been shown to promote epithelial-to-mesenchymal transition (EMT), driving disruption of cell-cell adhesion, cell migration and invasion. Here, we report that DCLK1 influences small extracellular vesicle (sEV/exosome) biogenesis in a kinase-dependent manner. sEVs isolated from DCLK1 overexpressing human GC cell line MKN1 (MKN1OE-sEVs), promote the migration of parental (non-transfected) MKN1 cells (MKN1PAR). Quantitative proteome analysis of MKN1OE-sEVs revealed enrichment in migratory and adhesion regulators (STRAP, CORO1B, BCAM, COL3A, CCN1) in comparison to MKN1PAR-sEVs. Moreover, using DCLK1-IN-1, a specific small molecule inhibitor of DCLK1, we reversed the increase in sEV size and concentration in contrast to other EV subtypes, as well as kinase-dependent cargo selection of proteins involved in EV biogenesis (KTN1, CHMP1A, MYO1G) and migration and adhesion processes (STRAP, CCN1). Our findings highlight a specific role of DCLK1-kinase dependent cargo selection for sEVs and shed new light on its role as a regulator of signaling in gastric tumorigenesis.


HelenAmelia Hains Fellowship; DF/HCCGI SPOREDevelopmental Research Project Award, Grant/Award Number: P50CA127003; HaleCenter forPancreaticResearch; La Trobe University, Grant/Award Numbers: RFAUnderstandingDisease grant, postgraduate research fellowship LTUPRS; Dana-Farber/Harvard CancerCenter, Grant/Award Number: DF/HCC GI SPORE/P50CA127003; National Health and Medical Research Council (NHMRC), Grant/Award Numbers: Investigator Grant/1183814, ProgramGrant/1092788, Project Grant/1139489, Senior Research Fellowship/1079257; StateGovernment ofVictoria, Grant/Award Number: Operational Infrastructure Support Program


Publication Date








Article Number








Rights Statement

The Author reserves all moral rights over the deposited text and must be credited if any re-use occurs. Documents deposited in OPAL are the Open Access versions of outputs published elsewhere. Changes resulting from the publishing process may therefore not be reflected in this document. The final published version may be obtained via the publisher’s DOI. Please note that additional copyright and access restrictions may apply to the published version.